Agency Onboard Report: Miami Vitality & Aesthetics — Sample

Miami Vitality & Aesthetics is a physician-led medspa and longevity-wellness clinic in Miami, Florida, serving an affluent local clientele plus Latin-American medical-tourism patients. Its menu spans IV therapy, hormone optimization, peptide protocols, and injectables (Botox, dermal fillers). On the surface this is a confident, fast-growing brand — ~260 Google reviews at 4.4★, a modern facility, an aggressive social presence, and a slick, conversion-minded website. But the composite of 47/100 (Grade C− — Below Average) reflects a sharp split: the practice markets and sells well (Marketing 58, Sales/conversion 55, Reputation 50) while sitting on existential regulatory exposure (Compliance 25) and weak machine-facing visibility (GEO/AI search 38).

The single biggest finding is not a marketing gap — it is claim risk. The same aggressive copy that drives conversion also makes disease-treatment, anti-aging, and outcome promises about IV drips, hormones, and peptides that the FDA and FTC read very differently than a prospect does. Structure/function language has drifted into implied disease claims; testimonials run without "results not typical" or substantiation; required disclaimers ("These statements have not been evaluated by the FDA…", "not FDA-approved" where relevant) are thin or missing. This is the rare case where the marketing engine is amplifying the liability. The second cluster is AI-search invisibility: when a Miami patient asks ChatGPT, Perplexity, or Google AI Overviews for "hormone optimization clinic Miami" or "peptide therapy near me", the practice is not named — the fastest-growing discovery channel is closed. Recommended starting point: a 30-day Claim-Safety + Findability sprint that de-risks the copy without gutting conversion, then an ongoing growth retainer.

Dimension details

Marketing (58/100)

Reputation (50/100)

GEO / AI search (38/100)

Sales / conversion (55/100)

Compliance — US (25/100)

Top 5 priority issues (ranked by revenue & risk impact)

• Disease/anti-aging claims without FDA framing (Source: Compliance) — Impact: Critical (existential regulatory). IV, NAD+, hormone, and peptide pages make implied disease-treatment and anti-aging promises ("reverse aging", "boost immunity", "treat chronic fatigue", "optimize testosterone to fix…") that read as drug/disease claims rather than permitted structure/function statements. The required "These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease" disclaimer is thin or absent, and several peptides marketed are not FDA-approved for the advertised use without a "not FDA-approved" notice. This is the single largest exposure in the audit and the reason Compliance scores 25.
• Testimonials without "results not typical" + substantiation (Source: Compliance/FTC) — Impact: Critical. Before/after transformations and patient quotes run as implied typical outcomes with no "results not typical" disclosure and no substantiation file behind performance claims. The FTC treats this as deceptive advertising under Section 5; health/wellness testimonials are a current enforcement priority. High visibility (these are the conversion hero assets) = high exposure.
• Invisible to AI assistants (Source: GEO — convergent with Marketing) — Impact: High (acquisition). Marketing-only pages, no plain-language Q&A/FAQ, no llms.txt, generic schema with no MedicalClinic/Physician/FAQPage/AggregateRating. When a Miami patient asks ChatGPT, Perplexity, or Google AI Overviews for "hormone clinic Miami" or "NAD+ IV near me", the practice is not cited. The fastest-growing discovery channel is closed despite strong conventional marketing.
• Pricing opacity drives the #1 review complaint (Source: Sales + Reputation — convergent) — Impact: High (conversion + reputation). Pricing is gated behind a consult and feels "upsell-y" to prospects; this is the dominant friction theme in reviews and the top pre-booking objection for a cash-pay audience. Some transparency (starting-price ranges, membership clarity) lifts both conversion and sentiment at once.
• Physician credentials & supervision not surfaced (Source: GEO + Compliance — convergent) — Impact: High (trust + Board exposure). The medical director and supervising physician credentials are barely visible; injector/NP supervision structure isn't stated. Florida Board of Medicine expects clear physician advertising and supervision framing for these services — and AI engines + patients both need named, credentialed authorship for E-E-A-T and trust. Hidden credentials hurt both compliance and citability.

All findings by lens

Marketing

• Strong, confident messaging and conversion-led design — a genuine asset; the engine works.
• Differentiation leans on hype ("the most advanced…") rather than substantiated, distinctive proof.
• Service-intent SEO is partial — strong on injectables, thinner on "peptide therapy Miami" / "NAD+ IV Miami" / "bioidentical hormones Miami" longevity queries.

Reputation

• Solid 4.4★ across ~260 reviews with an aggressive, well-fed social presence — real reach.
• ~12% owner-response rate — the large majority of reviews (positive and critical) go unanswered; a trust and AI signal left unused.
• Recurring friction themes — high/opaque pricing perceived as upsell-y and inconsistent results messaging — are addressable operationally, in responses, and on the pricing page.
• Elevated crisis vulnerability: aggressive health claims mean one negative outcome or regulatory inquiry could escalate publicly fast.

GEO / AI search

• No MedicalClinic/Physician schema, no FAQPage, no AggregateRating → the 4.4★ and service facts are invisible to machines.
• No llms.txt; no plain-language procedure Q&A — the two highest-leverage AI-citation surfaces are missing.
• Thin E-E-A-T: no named, credentialed authorship on clinical content; claims are marketing-voiced, not expertise-voiced — the opposite of what AI engines cite.

Sales / conversion

• Booking and lead capture are strong; intent-matched service pages convert.
• Pricing is fully gated — friction for a comparison-shopping cash-pay buyer.
• After-hours / Spanish-language enquiry follow-up for the medical-tourism segment appears un-sequenced.

Compliance (US)

• Implied disease/anti-aging claims on IV/NAD+/hormone/peptide pages without FDA structure/function discipline or the "not evaluated by the FDA" disclaimer (FDA).
• Testimonials/before-afters without "results not typical" disclosure or substantiation file (FTC Section 5).
• Non-FDA-approved peptide uses marketed without a "not FDA-approved" notice (FDA).
• Physician/supervision framing thin for Board of Medicine advertising expectations; intake/contact forms collect clinical detail — HIPAA points to a secure channel + clear privacy practices, not open web forms.

• Add the FDA disclaimer + soften disease language (Compliance) — Effort: Low–Med | Impact: Critical. Add the "These statements have not been evaluated by the FDA…" disclaimer to wellness pages and reframe disease verbs ("treat/cure/reverse") into compliant structure/function language ("supports", "helps maintain"). Removes the single largest exposure category — start this week.
• Fix testimonials (Compliance/FTC) — Effort: Low | Impact: Critical. Add "results not typical" to before/after and patient quotes and start a substantiation file for any performance claim. Keeps the conversion assets while de-risking them.
• Publish starting-price ranges + membership clarity (Sales/Reputation) — Effort: Low | Impact: High. Defuses the #1 "upsell-y" complaint and the top pre-booking objection in one move.
• Turn on owner-responses (Reputation) — Effort: Low | Impact: Med-High. Reply to the last ~25 reviews; set a 48-hour SLA. Lifts trust and a signal AI weighs.
• Ship MedicalClinic + FAQPage + AggregateRating schema and llms.txt (GEO) — Effort: Low | Impact: High. Makes the 4.4★, services, and answers machine-readable; few medspa sites have these.

Tier 1 — Claim-Safety & Comply ($1,200–$3,500 one-time + light monthly)

Stops the bleeding. FDA disclaimer rollout + structure/function rewrite of claim-heavy pages; "results not typical" + substantiation-file setup for testimonials; "not FDA-approved" notices where relevant; physician/supervision framing; HIPAA-minded form review; schema upgrade (MedicalClinic/FAQPage/AggregateRating); llms.txt; review-response routine set up.
Best for: closing the existential FDA/FTC exposure and findability basics before scaling ad spend.

Tier 2 — Findability Growth ($1,500–$4,000/mo) ← recommended start

Tier 1, plus the authority + GEO + conversion buildout: named, credentialed physician/clinician pages (E-E-A-T), plain-language procedure content + FAQ (the quotable AI layer for hormones/peptides/IV/NAD+), service-intent pages for longevity queries, transparent starting-price + membership content, GBP optimization, and bilingual (EN/ES) enquiry follow-up for the medical-tourism segment.
Best for: Miami Vitality right now — de-risks the brand, unlocks AI search, lifts conversion in 90 days.

Tier 3 — Full Presence + MRR ($4,000–$8,000/mo +)

Tier 2, plus an ongoing compliant content + social engine, monthly geo-compare delta reporting, reviews + response service, crisis-readiness playbook (given the elevated claim exposure), and the optional AI Audit Copilot (this audit turned into a chat assistant the team can ask "what do we do this week?"). Compounding, defensible, AI-cited local authority.
Best for: a 6–12 month engagement once the foundation is live.

Prices illustrative; finalized after pilot economics.

Phase 1 — Claim-Safety & Comply (Days 1–30)

• Add "These statements have not been evaluated by the FDA…" disclaimer to wellness/longevity pages
• Rewrite disease/anti-aging verbs → compliant structure/function language (FDA)
• Add "results not typical" to testimonials/before-afters; open a substantiation file (FTC)
• Add "not FDA-approved" notices for relevant peptide uses
• Strengthen physician/supervision framing (FL Board of Medicine)
• Review intake/contact forms for HIPAA; route clinical detail to a secure channel
• Deploy MedicalClinic + FAQPage + AggregateRating schema; publish llms.txt
• Reply to last ~25 reviews; set 48-hour response SLA

Phase 2 — Trust + Findability (Days 31–60)

• Named, credentialed physician/clinician pages (E-E-A-T) with qualifications + supervision structure
• Plain-language procedure content + FAQ (IV/NAD+, hormones, peptides, injectables) — quotable AI layer
• Service-intent pages for longevity queries (peptide therapy / NAD+ IV / bioidentical hormones Miami)
• Transparent starting-price ranges + membership clarity page
• GBP optimization (categories, services, hours, Q&A, posts); verify SSR for AI crawlers

Phase 3 — Conversion + Compounding (Days 61–90)

• Bilingual (EN/ES) enquiry follow-up + nurture sequence for medical-tourism segment
• Compliant before/after with consent + "results not typical"; trust bar (credentials, 4.4★)
• Steady review-request routine (post-visit)
• Crisis-readiness playbook for claim/outcome inquiries
• Monthly KPI rollup: AI mentions, review volume/rating/response, organic + booking conversion
• Optional: stand up the AI Audit Copilot for the team

Miami Vitality competes on three fronts. First, other South Florida medspas / longevity clinics (illustrative composites: "Brickell Longevity Lab" and "Coral Wellness Rx") — several market just as aggressively, so the differentiation race is real but no one has yet built a compliant, credentialed, AI-citable content layer; that position is open. Second, dermatology and aesthetic practices competing for the injectables patient, where Miami Vitality's physician-led, full-longevity menu is a differentiator it currently buries under hype rather than credibility. Third, AI-search visibility for "hormone optimization / NAD+ IV / peptide therapy / Botox Miami" queries, where the practice is currently unnamed by ChatGPT, Perplexity, and AI Overviews. The thesis is distinctive to this subject: Miami Vitality is out-marketing the field on hype but under-protected and under-structured — whoever ships compliant E-E-A-T content + schema first owns the AI-cited local authority position and lowers their regulatory profile while doing it. The engagement is a de-risk-and-compound sprint, not a catch-up one.

• Review this report — treat the Compliance section as urgent; the FDA disclaimer + testimonial fixes are a same-week change with existential downside if ignored.
• 30-minute walk-through to prioritize the 90-day plan and the claim-safety rewrite scope.
• Free snapshot → paid engagement: start with the Phase-1 claim-safety quick wins this week.

Prepared by R·N·D Presence (an R·N·D Group practice). Full audit battery — composite over GEO, reputation, marketing, sales/conversion, and US health-marketing compliance (FDA/FTC/Florida Board of Medicine/HIPAA) — modelled on our standard deliverable format. Composite fictional data; benchmarks, not a guarantee of rankings or results. Compliance = marketing read, not legal advice.

• GEO / AI search audit — citability, schema, llms.txt and platform visibility across ChatGPT, Perplexity and AI Overviews.
• Reputation audit — review volume, rating, sentiment themes, response rate and crisis vulnerability.
• Owner-responses audit — the unanswered-review backlog and paste-ready response drafts.
• Ads & landing-page audit — ad-to-page message match, CTA clarity, trust signals and form friction.
• Audience audit — detailed buyer personas, pain points and platform-specific targeting.

We run the same battery on your real site, Google profile and listings.